Loading...
XNASAQB
Market cap2mUSD
Dec 24, Last price  
0.68USD
1D
17.00%
1Q
-38.35%
IPO
-79.57%
Name

AquaBounty Technologies Inc

Chart & Performance

D1W1MN
XNAS:AQB chart
P/E
—
P/S
1.06
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
42.62%
Rev. gr., 5y
96.45%
Revenues
2m
-21.18%
777,575225,779281,07856,8690000000053,27884,518186,738127,6631,174,8323,136,9542,472,659
Net income
-28m
L+25.32%
000-6,656,683000-4,414,613-4,689,038-7,127,375-7,031,512-8,470,661-9,258,647-10,382,059-13,304,620-16,552,564-22,754,649-21,990,852-27,557,901
CFO
-24m
L+15.37%
-1,926,736000000-3,715,455-4,457,628-6,560,900-6,748,298-7,448,893-9,100,778-9,816,765-11,248,747-14,288,821-20,472,259-21,006,830-24,236,245
Earnings
May 13, 2025

Profile

AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.
URL
https://aquabounty.com/
IPO date
Jan 09, 2017
Employees
100
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
2,473
-21.18%
3,137
167.01%
1,175
820.26%
Cost of revenue
29,698
25,460
23,297
Unusual Expense (Income)
NOPBT
(27,226)
(22,324)
(22,122)
NOPBT Margin
Operating Taxes
(166)
432
Tax Rate
NOPAT
(27,226)
(22,157)
(22,554)
Net income
(27,558)
25.32%
(21,991)
-3.36%
(22,755)
37.47%
Dividends
Dividend yield
Proceeds from repurchase of equity
1,538
119,120
BB yield
-2.83%
-81.70%
Debt
Debt current
826
2,387
627
Long-term debt
8,243
6,693
8,971
Deferred revenue
Other long-term liabilities
Net debt
856
(93,559)
(181,630)
Cash flow
Cash from operating activities
(24,236)
(21,007)
(20,472)
CAPEX
(68,890)
(67,476)
(5,714)
Cash from investing activities
(68,893)
34,350
(107,539)
Cash from financing activities
(308)
(162)
121,179
FCF
(93,271)
(94,567)
(29,273)
Balance
Cash
8,214
101,639
190,229
Long term investments
1,000
1,000
Excess cash
8,090
102,482
191,170
Stockholders' equity
(220,981)
(193,468)
(171,049)
Invested Capital
394,786
394,265
394,227
ROIC
ROCE
EV
Common stock shares outstanding
3,844
3,553
3,471
Price
2.85
-81.35%
15.28
-63.62%
42.00
-76.03%
Market cap
10,956
-79.82%
54,296
-62.76%
145,799
-54.21%
EV
11,812
(39,262)
(35,831)
EBITDA
(25,068)
(20,299)
(20,334)
EV/EBITDA
1.93
1.76
Interest
304
291
316
Interest/NOPBT